This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2226) Registered Report (528) Mobile Health (mhealth) (2777) mHealth for Wellness, Behavior Change and Prevention (2754)

Published on in Vol 6, No 10 (2022): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41415, first published .
Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study

Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study

Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study

Authors of this article:

Sherif M Badawy1, 2 Author Orcid Image ;   Lisa DiMartino3 Author Orcid Image ;   Donald Brambilla3 Author Orcid Image ;   Lisa Klesges4 Author Orcid Image ;   Ana Baumann4 Author Orcid Image ;   Ebony Burns5 Author Orcid Image ;   Terri DeMartino5 Author Orcid Image ;   Sara Jacobs3 Author Orcid Image ;   Hamda Khan6 Author Orcid Image ;   Chinonyelum Nwosu6 Author Orcid Image ;   Nirmish Shah5 Author Orcid Image ;   Jane S Hankins6, 7 Author Orcid Image ;   Sickle Cell Disease Implementation Consortium8
Article Authors Cited by (5) Tweetations (8) Metrics

Sherif M Badawy   1, 2 * , MD, MBBCh, MS ;   Lisa DiMartino   3 * , MPH, PhD ;   Donald Brambilla   3 , PhD ;   Lisa Klesges   4 , PhD ;   Ana Baumann   4 , PhD ;   Ebony Burns   5 , MA ;   Terri DeMartino   5 , BA ;   Sara Jacobs   3 , PhD ;   Hamda Khan   6 , MA ;   Chinonyelum Nwosu   6 , MPH ;   Nirmish Shah   5 , MD, MS ;   Jane S Hankins   6, 7 , MD, MS ;   Sickle Cell Disease Implementation Consortium   8 *

1 Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States

2 Department of Pediatrics, Northwestern University Feinberg School Medicine, Chicago, IL, United States

3 RTI International, Research Triangle Park, NC, United States

4 Department of Surgery, Washington University in St. Louis, St. Louis, MO, United States

5 Division of Hematology, Duke University School of Medicine, Durham, NC, United States

6 Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, United States

7 University of Tennessee Health Science Center, Memphis, TN, United States

8 See Acknowledgements

*these authors contributed equally

Corresponding Author:

  • Jane S Hankins, MD, MS
  • Department of Hematology
  • St. Jude Children's Research Hospital
  • 262 Danny Thomas Place, Mail Stop 800
  • Memphis, TN, 38105
  • United States
  • Phone: 1 901 5954153
  • Fax: 1 901 5952952
  • Email: jane.hankins@stjude.org